Takara Bio Inc. (TYO:4974)
Japan flag Japan · Delayed Price · Currency is JPY
797.00
-19.00 (-2.33%)
At close: Feb 6, 2026

Takara Bio Revenue

Takara Bio had revenue of 9.53B JPY in the quarter ending September 30, 2025, a decrease of -15.42%. This brings the company's revenue in the last twelve months to 44.08B, down -0.16% year-over-year. In the fiscal year ending March 31, 2025, Takara Bio had annual revenue of 45.04B with 3.53% growth.

Revenue (ttm)
44.08B
Revenue Growth
-0.16%
P/S Ratio
2.18
Revenue / Employee
24.78M
Employees
1,779
Market Cap
95.97B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 202545.04B1.53B3.53%
Mar 31, 202443.51B-34.64B-44.33%
Mar 31, 202378.14B10.44B15.43%
Mar 31, 202267.70B21.61B46.90%
Mar 31, 202146.09B11.52B33.33%
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Nxera Pharma28.70B
GNI Group25.78B
PeptiDream17.93B
RaQualia Pharma3.05B
Japan Tissue Engineering2.26B
AnGes818.00M
Cuorips360.00M
Healios K.K.97.00M
Revenue Rankings